EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO)-41ST ANNUAL CONGRESS, FROM DISEASE TREATMENT TO PATIENT CARE

被引：0
|
作者：
Watt, J. [1 ]
机构：
[1] Clarivate Analyt, London, England
来源：
DRUGS OF THE FUTURE | 2016年 / 41卷 / 11期
关键词：
Prexasertib; WK-0202; MEDI-0680; Nivolumab; Pembrolizumab;
D O I：
10.1358/dof.2016.041.11.2556710
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The 2016 edition of the Annual ESMO Congress brought stakeholders in the medical oncology area to Copenhagen and gave them a platform on which to present current research and developments. Researchers, clinicians and patients focused on finding effective treatments and solutions to improve the life of those affected by cancer. This report covers highlights from the 5-day meeting.
引用
收藏
页码：699 / 701
页数：3
相关论文
共 50 条
12345